Patents by Inventor Thomas Haberberger

Thomas Haberberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REGULATION OF MINERAL AND SKELETAL METABOLISM
    Publication number: 20110251124
    Abstract: A method is disclosed whereby levels of calcium, phosphate and parathyroid hormone are measured in a patient. The patient is treated with a formulation comprising a compound having phosphotonin activity and thereafter measurements are made again. Dosing of the formulation is adjusted based on measurements with measuring, administering and adjusting dosing continually repeated as needed.
    Type: Application
    Filed: December 14, 2010
    Publication date: October 13, 2011
    Inventors: Thomas Haberberger, David Rosen, Yoshinari Kumagai
  • REGULATION OF MINERAL AND SKELETAL METABOLISM
    Publication number: 20090029915
    Abstract: A method is disclosed whereby levels of calcium, phosphate and parathyroid hormone are measured in a patient. The patient is treated with a formulation comprising a compound having phosphotonin activity and thereafter measurements are made again. Dosing of the formulation is adjusted based on measurements with measuring, administering and adjusting dosing continually repeated as needed.
    Type: Application
    Filed: October 29, 2007
    Publication date: January 29, 2009
    Inventors: Thomas Haberberger, David Rosen, Yoshinari Kumagai
  • REGULATION OF MINERAL AND SKELETAL METABOLISM
    Publication number: 20090023634
    Abstract: A method is disclosed whereby levels of calcium, phosphate and parathyroid hormone are measured in a patient. The patient is treated with a formulation comprising a compound having phosphotonin activity and thereafter measurements are made again. Dosing of the formulation is adjusted based on measurements with measuring, administering and adjusting dosing continually repeated as needed.
    Type: Application
    Filed: October 29, 2007
    Publication date: January 22, 2009
    Inventors: Thomas Haberberger, David Rosen, Yoshinari Kumagai
  • REGULATION OF MINERAL AND SKELETAL METABOLISM
    Publication number: 20090023633
    Abstract: A method is disclosed whereby levels of calcium, phosphate and parathyroid hormone are measured in a patient. The patient is treated with a formulation comprising a compound having phosphotonin activity and thereafter measurements are made again. Dosing of the formulation is adjusted based on measurements with measuring, administering and adjusting dosing continually repeated as needed.
    Type: Application
    Filed: October 29, 2007
    Publication date: January 22, 2009
    Inventors: Thomas Haberberger, David Rosen, Yoshinari Kumagai
  • REGULATION OF MINERAL AND SKELETAL METABOLISM
    Publication number: 20090018064
    Abstract: A method is disclosed whereby levels of calcium, phosphate and parathyroid hormone are measured in a patient. The patient is treated with a formulation comprising a compound having phosphotonin activity and thereafter measurements are made again. Dosing of the formulation is adjusted based on measurements with measuring, administering and adjusting dosing continually repeated as needed.
    Type: Application
    Filed: October 29, 2007
    Publication date: January 15, 2009
    Inventors: Thomas Haberberger, David Rosen, Yoshinari Kumagai
  • REGULATION OF MINERAL AND SKELETAL METABOLISM
    Publication number: 20070066514
    Abstract: A method is disclosed whereby levels of calcium, phosphate and parathyroid hormone are measured in a patient. The patient is treated with a formulation comprising a compound having phosphotonin activity and thereafter measurements are made again. Dosing of the formulation is adjusted based on measurements with measuring, administering and adjusting dosing continually repeated as needed.
    Type: Application
    Filed: August 23, 2006
    Publication date: March 22, 2007
    Inventors: Thomas Haberberger, David Rosen, Yoshinari Kumagai